Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.44 SEK | -2.48% | +8.26% | +29.67% |
Mar. 25 | Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader | CI |
Mar. 22 | SenzaGen AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 67.55M 6.23M | Sales 2025 * | 91.65M 8.45M | Capitalization | 234M 21.58M |
---|---|---|---|---|---|
Net income 2024 * | -15M -1.38M | Net income 2025 * | -4M -369K | EV / Sales 2024 * | 3.35 x |
Net cash position 2024 * | 8M 737K | Net cash position 2025 * | 9M 829K | EV / Sales 2025 * | 2.46 x |
P/E ratio 2024 * |
-15.6
x | P/E ratio 2025 * |
-56.9
x | Employees | 34 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.56% |
Latest transcript on SenzaGen AB
1 day | +2.33% | ||
1 week | +10.76% | ||
Current month | +38.29% | ||
1 month | +21.00% | ||
3 months | +42.35% | ||
6 months | +28.04% | ||
Current year | +32.97% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Nählstedt
CEO | Chief Executive Officer | 50 | 17-12-31 |
Marianne Olsson
DFI | Director of Finance/CFO | 63 | 16-10-31 |
Henrik Johansson
CTO | Chief Tech/Sci/R&D Officer | 42 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 76 | 10-08-17 | |
Director/Board Member | 59 | 14-10-14 | |
Paula Zeilon
BRD | Director/Board Member | 62 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 9.44 | -2.48% | 27 210 |
24-05-13 | 9.68 | +2.33% | 47,678 |
24-05-10 | 9.46 | -0.42% | 18,762 |
24-05-08 | 9.5 | +8.94% | 43,892 |
24-05-07 | 8.72 | -0.23% | 26,945 |
Delayed Quote Nasdaq Stockholm, May 13, 2024 at 11:29 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.97% | 21.59M | |
-24.86% | 10.26B | |
-11.28% | 2.94B | |
-12.92% | 2.19B | |
-18.21% | 1.72B | |
+60.76% | 1.4B | |
+24.83% | 780M | |
-4.59% | 736M | |
-22.45% | 560M | |
-0.60% | 293M |
- Stock Market
- Equities
- SENZA Stock